Male factor infertility is involved in roughly half of couples who do not conceive after a year of trying. The depth of investigation a man receives varies enormously. Some men get a full hormonal panel, a scrotal ultrasound, and DNA fragmentation testing before anyone discusses treatment. Others hand over a semen sample and hear little more than "wait in the hall." The clinic's structure and priorities explain that gap more than any difference in sperm count.
The andrology gap
A core difference is whether the clinic treats male fertility as a subspecialty or as a side note. Reproductive endocrinologists train primarily in the female reproductive system. Many clinics are built around that expertise. When a couple walks in, the workup may focus heavily on ovarian reserve, fallopian tubes, and uterine lining. The male side often starts and ends with one semen analysis.
Other clinics employ board-certified male reproductive urologists, sometimes called andrologists. These are urologists who completed additional training in male reproduction. An andrologist thinks beyond count and motility. They examine the testicles, check for varicoceles, look at hormone levels, and ask about prior surgeries, medications, and heat exposure. The presence of one person on staff who owns the male workup changes how quickly reversible causes get found.
Ask directly who interprets the male results. If the answer is "the reproductive endocrinologist" and there is no urologist on staff, the male investigation may stay basic. If a reproductive urologist reviews results, the conversation usually widens.
What a full male workup actually includes
The baseline everywhere is a semen analysis. The World Health Organization's laboratory manual for the examination and processing of human semen, now in its sixth edition from 2021, sets reference values for volume, count, motility, and morphology. A lab that runs samples against WHO sixth edition criteria gives you a standard comparison point. A lab that follows older fifth edition values or uses in-house norms can shift the numbers enough to change a clinical decision.
Beyond the baseline, clinics diverge quickly. A fuller workup can include:
- Hormone panel: follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone, estradiol, and prolactin. These five values separate testicular failure from pituitary signaling problems, which lead to entirely different treatments.
- Scrotal ultrasound: finds varicoceles, hydroceles, and testicular masses that a physical exam can miss.
- DNA fragmentation testing: sperm DNA can be damaged even when count and motility look normal. Tests include SCSA, TUNEL, and SCD. Some clinics run this routinely on the first visit. Others only order it after unexplained IVF failure or miscarriage.
- Genetic testing: karyotype, Y-chromosome microdeletion analysis, and cystic fibrosis carrier testing have specific indications, especially when counts are severely low.
- Antisperm antibody testing: relevant when there is a history of testicular trauma, surgery, or vasectomy reversal.
The sequencing matters. Some clinics re-run a basic semen analysis first, because one abnormal sample is not enough to diagnose anything and the WHO manual recommends confirmation with a second sample. Others jump from one abnormal result to treatment planning. That sequencing difference reflects how conservatively a clinic practices.
Treatment philosophy differs by clinic
Once a diagnosis exists, clinics split into two broad camps. Some pursue reversible causes before assisted reproduction. Others move to in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) as the first stop.
Varicocele repair is the clearest example. A varicocele is an enlarged vein in the scrotum. Evidence from randomized trials and meta-analyses indicates that varicocele repair can improve sperm parameters in some men, particularly when the varicocele is palpable and the initial count is low. Some reproductive urologists will offer surgery before IVF. Other clinics, particularly those without a surgical urologist on staff, will not raise varicocele repair as an option and will go straight to ICSI. Both paths can work. One costs a surgical recovery. The other commits you to assisted reproduction. A clinic with surgical capability can present both options. A clinic without it can only present one.
Hormonal treatment shows a similar split. Men with true hypogonadotropic hypogonadism, a rare condition where the pituitary fails to send signals to the testicles, may respond to gonadotropin injections or other hormonal therapy. Some clinics work this up and treat it. Others skip the endocrine investigation and proceed to sperm extraction. The difference in clinic philosophy determines whether a man hears about a hormonal option at all.
Then there is the IVF threshold question. For mild male factor, intrauterine insemination (IUI) is sometimes a step between lifestyle changes and IVF. Clinics set different cutoffs for when they recommend IUI versus IVF with ICSI. One clinic may recommend ICSI for any count below 10 million per milliliter. Another may try IUI down to 5 million. These thresholds are not standardized. They reflect the clinic's tolerance for waiting and its economic incentives. IVF cycles generate more revenue than monitored IUI cycles. An honest clinic will explain why they recommend the faster route. A less transparent one just writes the order.
The male experience inside the building
Fertility care is emotionally loaded before a man ever swallows the word "motility." How the clinic treats the man himself varies as much as the medical protocols.
Consider the collection process. Some clinics have private, dedicated collection rooms with recliners and a door that locks. Others hand you a cup and point to a bathroom near the lab. The difference is not cosmetic. Producing a sample on demand, under time pressure, in a clinical setting is a known source of anxiety. A clinic that designs for it recognizes the man as a patient. One that does not treats him as an input.
Scheduling also differs. A consolidated male workup might happen in one morning: blood draw, physical exam, ultrasound, and collection. A fragmented one sends a man back four times on four different mornings. If a clinic cannot consolidate the baseline visit, that is a signal about how they think about the male partner's time.
Abstinence windows are another operational difference. The WHO manual recommends 2 to 7 days of abstinence before a sample. Some clinics give a range and explain why. Others give one number and no rationale. When instructions are vague, men second guess themselves, which compounds stress.
Psychological support is the quiet piece. Male factor infertility carries a distinct stigma, and men in this situation often have no outlet because the conversation runs through their partner's body. Some clinics employ or refer to a therapist with experience in male reproductive grief. Asking about counseling is a reasonable screen for whether a clinic sees the whole person.
Lab quality and technology
Not all semen analyses are equal. Accreditation changes the confidence you can place in a result. In the United States, look for CLIA certification for the lab and CAP accreditation as a higher standard. Internationally, ISO 15189 is the relevant accreditation for medical laboratories. A clinic that outsources semen analysis to a non-accredited lab is a different proposition than one with an on-site accredited andrology laboratory. Andrology lab errors are a documented problem, particularly in morphology scoring, which is subjective and training dependent.
On the treatment side, advanced sperm selection techniques are a differentiator. PICSI selects sperm based on their binding to hyaluronan, which may indicate maturity. MACS uses a magnetic field to remove sperm with fragmented DNA based on an external marker. Microfluidic sorting channels, such as ZyMot, select sperm by their ability to swim through a membrane, which may reduce oxidative stress compared to traditional centrifugation. The evidence base for these techniques is mixed. Some show improvements in selected populations. Others show no difference in live birth rates. A clinic that uses advanced selection should be able to explain what they use, why, and what the supporting evidence says. A clinic that cannot explain is selling technology, not a plan.
Surgical sperm retrieval is another capability gap. When no sperm is present in the ejaculate, options include testicular sperm extraction (TESE) and microTESE, a microscope-guided procedure that removes small amounts of testicular tissue to find sperm. MicroTESE requires a urologist trained in the microsurgical technique with an operating microscope. Not all clinics offer it. If your workup points toward obstructive or non-obstructive azoospermia, the availability of microTESE on staff becomes a deciding factor.
How success rates are reported
Fertility clinics in the United States report outcomes to the Centers for Disease Control and Prevention (CDC) and the Society for Assisted Reproductive Technology (SART). The annual Fertility Clinic Success Rate Report is public. That is a starting point, but the framing matters more than the raw number.
Clinics differ in what denominator they lead with. A clinic may advertise its live birth rate per embryo transfer. Another may report per egg retrieval or per cycle started. Cumulative rates per retrieval, which include frozen embryo transfers from the same cycle, are the most informative for a patient. Per-transfer rates look different because they exclude cycles that never made it to transfer. A clinic that leads with per-transfer rates is choosing the more flattering number.
For male factor specifically, there is an extra complication. The national reports do not break out male factor outcomes separately in most circumstances. That means you cannot directly compare "how good is this clinic at male factor" using the public data. You have to ask the clinic for their internal data, if they have it, and listen carefully to whether they provide it or deflect.
Cost, insurance, and the financial conversation
Male diagnostics are cheaper than IVF, but they are not free. A full hormonal panel, scrotal ultrasound, DNA fragmentation test, and genetic screening can run into the hundreds or low thousands of dollars before treatment starts. Some clinics bundle these into a fixed male workup price. Others bill each test separately. The difference shows up on the first statement.
Insurance coverage compounds the variance. In the United States, some states mandate fertility coverage, including male evaluation. The CDC and RESOLVE track these mandates. In states without mandates, coverage depends on the employer plan. A clinic that handles insurance verification proactively and explains out-of-pocket costs before ordering a test is structurally different from one that sends the bill and waits.
Surgical options carry their own costs. Varicocele repair, TESE, and microTESE have different surgical fees, anesthesia charges, and recovery time. A clinic that does not employ a urologist cannot quote these costs because they do not perform them. They refer out, and the costs become someone else's conversation.
Geographic and referral differences
Location matters in two ways. First, access to male specialists is uneven. Major academic medical centers and large urban clinics are more likely to have reproductive urologists, genetic counselors, and accredited andrology labs on site. Rural and smaller practices are more likely to refer out or skip expanded testing.
Second, state laws shape what is available. States differ on insurance mandates, embryo disposition rules, and restrictions on certain procedures. A clinic in one state may offer a treatment pathway that a clinic across the state line cannot. For men, the relevant legal differences usually involve insurance coverage for male diagnostics and access to genetic testing.
Multidisciplinary referral patterns are the final structural difference. A strong clinic coordinates. The reproductive endocrinologist talks to the reproductive urologist. The urologist refers to a genetic counselor. The mental health provider sits in the same building or the same referral network. A fragmented clinic hands you three separate phone numbers and lets you make the calls yourself. Coordination reduces the chance that a finding gets dropped between specialists.
How to evaluate a clinic as a male patient
The most direct way to compare clinics is to ask the same set of questions at each one and compare the answers. Worth asking, whether by phone or at a consultation:
- Is there a reproductive urologist or male reproductive specialist on staff?
- Who interprets the semen analysis, and does the lab use WHO sixth edition reference values?
- What does your typical male workup include on the first visit?
- After one abnormal semen analysis, what is the next step?
- Do you run DNA fragmentation testing routinely, or only in specific situations?
- Under what parameters do you recommend IUI versus IVF with ICSI?
- Do you perform varicocele repair, TESE, and microTESE on site?
- How do you report success rates, and can you share cumulative outcomes per retrieval?
- What are the out-of-pocket costs for the male workup, itemized?
- Do you have a mental health professional or support resource for the male partner?
The pattern in the answers matters more than any single response. A clinic that answers directly, cites its own thresholds, and names who does what is built for the male patient. A clinic that deflects, minimizes, or has no male specialist is built around someone else.
Individual situations vary, and a reproductive urologist or endocrinologist can interpret these options for your specific case.
One more practical point. If you have not had a male evaluation yet, the American Society for Reproductive Medicine and the American Urological Association both recommend starting with a male evaluation before or alongside the female workup. That recommendation exists because male factor is common and cheaper to investigate than much of the female workup. Walking into a consultation knowing that the male side deserves a full investigation changes the conversation. The male evaluation belongs in the initial standard for infertility care.
This content is for educational purposes only and is not medical advice. Oakman products are designed for physical comfort and cooling. They make no claims about fertility, sperm quality, or hormone levels. Consult a healthcare professional for personalized advice.